These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prognostic factors for primary gastrointestinal stromal tumours: are they the same in the multidisciplinary treatment era? Cananzi FC, Lorenzi B, Belgaumkar A, Benson C, Judson I, Mudan S. Langenbecks Arch Surg; 2014 Mar; 399(3):323-32. PubMed ID: 24413830 [Abstract] [Full Text] [Related]
23. Gastrointestinal stromal tumors: diagnosis and treatment. Acín-Gándara D, Pereira-Pérez F, Castaño-Pascual A, Durán-Poveda M, Antequera-Pérez A, Miliani-Molina C. Cir Cir; 2012 Mar; 80(1):44-51. PubMed ID: 22472152 [Abstract] [Full Text] [Related]
25. Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinib. Wilkinson MJ, Fitzgerald JE, Strauss DC, Hayes AJ, Thomas JM, Messiou C, Fisher C, Benson C, Tekkis PP, Judson I. Br J Surg; 2015 Jul; 102(8):965-71. PubMed ID: 25970743 [Abstract] [Full Text] [Related]
31. The management of gastrointestinal stromal tumors: a model for targeted and multidisciplinary therapy of malignancy. Joensuu H, DeMatteo RP. Annu Rev Med; 2012 Dec; 63():247-58. PubMed ID: 22017446 [Abstract] [Full Text] [Related]
32. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Gold JS, Gönen M, Gutiérrez A, Broto JM, García-del-Muro X, Smyrk TC, Maki RG, Singer S, Brennan MF, Antonescu CR, Donohue JH, DeMatteo RP. Lancet Oncol; 2009 Nov; 10(11):1045-52. PubMed ID: 19793678 [Abstract] [Full Text] [Related]
33. Extended adjuvant therapy with imatinib in patients with gastrointestinal stromal tumors : recommendations for patient selection, risk assessment, and molecular response monitoring. Rutkowski P, Przybył J, Zdzienicki M. Mol Diagn Ther; 2013 Feb; 17(1):9-19. PubMed ID: 23355099 [Abstract] [Full Text] [Related]
35. Management of gastrointestinal stromal tumors: looking beyond the knife. An update on the role of adjuvant and neoadjuvant imatinib therapy. Pandey R, Kochar R. J Gastrointest Cancer; 2012 Dec; 43(4):547-52. PubMed ID: 22847491 [Abstract] [Full Text] [Related]
37. Prognostic factors in surgically managed gastrointestinal stromal tumours. Wu XJ, Zhang RX, Chen G, Fang YJ, Ding PR, Li LR, Lu ZH, Kong LH, Pan ZZ, Wan DS. J Int Med Res; 2012 Dec; 40(5):1904-11. PubMed ID: 23206474 [Abstract] [Full Text] [Related]
38. Current management of gastrointestinal stromal tumors--a comprehensive review. Lai EC, Lau SH, Lau WY. Int J Surg; 2012 Dec; 10(7):334-40. PubMed ID: 22633986 [Abstract] [Full Text] [Related]